1. Risk: AI Monoculture (Shared Blind Spots). This is the most critical and overlooked systemic vulnerability. Building your ...

Explore the top predictions for Layer 2 adoption in 2026. Learn how rollups, data availability, AI agents, and modular ...

For years, Total Value Locked (TVL) has been the canary in DeFi's coalmine. When it was up, the sector was ‘thriving'. When it was down, DeFi was ‘in decline'. During 2025, that narrative began to ...

Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to ...

One of the most detailed 3D maps of how the human chromosomes are organized and folded within a cell's nucleus is published ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Investing.com -- Recursion Pharmaceuticals (NASDAQ:RXRX) stock rose 7% Monday following positive Phase 2 trial results for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), a ...

Hi, everyone, and welcome. I'm Najat Khan, Recursion's Chief R&D and Chief Commercial Officer and incoming CEO and President. Let's jump right in. Today is an important moment for Recursion, for our ...

Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...

Duplicates of crystal structures are flooding databases, implicating repositories hosting organic, inorganic, and ...